Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

123 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153

Conditions
Advanced Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations
  • Site Reference ID/Investigator# 50065 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 50059 Fountain Valley, California, United States
  • Site Reference ID/Investigator# 50048 Los Angeles, California, United States
  • Site Reference ID/Investigator# 50076 Oceanside, California, United States
View all 83 locations
View Trial Details
Completed

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

NCT00360568

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • Site Reference ID/Investigator# 45869 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 45834 Fountain Valley, California, United States
  • Site Reference ID/Investigator# 45854 Los Angeles, California, United States
  • Site Reference ID/Investigator# 45856 Oceanside, California, United States
View all 22 locations
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

NCT00357994

Conditions
Advanced Parkinson's Disease, Central Nervous System Diseases, Dyskinesias, +5 more
Locations
  • Site Reference ID/Investigator# 45719 Los Angeles, California, United States
  • Site Reference ID/Investigator# 45718 Englewood, Colorado, United States
  • Site Reference ID/Investigator# 45722 Washington D.C., District of Columbia, United States
  • Site Reference ID/Investigator# 45721 Bradenton, Florida, United States
View all 15 locations
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

NCT00660387

Conditions
Advanced Parkinson's Disease, Central Nervous System Diseases, Dyskinesias, +5 more
Locations
  • Site Reference ID/Investigator# 45931 Birmingham, Alabama, United States
  • Site Reference ID/Investigator# 45910 Fountain Valley, California, United States
  • Site Reference ID/Investigator# 45925 Oceanside, California, United States
  • Site Reference ID/Investigator# 45912 Port Charlotte, Florida, United States
View all 14 locations
View Trial Details
Completed

Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial

NCT01076452

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • VA Medical Center, San Francisco San Francisco, California, United States
  • VA Greater Los Angeles Healthcare System, West LA West Los Angeles, California, United States
View all 14 locations
View Trial Details
Completed

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

NCT00056563

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • VA Medical Center, San Francisco San Francisco, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • VA Greater Los Angeles Healthcare System, West LA West Los Angeles, California, United States
View all 14 locations
View Trial Details
Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

NCT01485965

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • Washington University St Louis, Missouri, United States
  • University of Rochester Rocherster, New York, United States
View Trial Details

Related conditions